IRIS (International Remote Imaging Systems) signs letter of intent for sale of unit:
This article was originally published in Clinica
Executive Summary
International Remote Imaging Systems (IRIS) has signed a letter of intent with an unnamed international company for the sale of its Perceptive Scientific Instruments subsidiary for between $2.5 million and $5 million. The division makes and markets the PowerGene line of genetic analysers. The Chatsworth, California-based company announced plans to refocus operations on its core urinalysis business and write off assets relating to non-core operations (see Clinica No 885, p 12). IRIS intends to develop lower-cost, faster imaging products.